{{Rsnum
|rsid=619289
|Gene=MYBL2
|Chromosome=20
|position=43665973
|Orientation=plus
|GMAF=0.2268
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MYBL2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 81.4 | 17.7 | 0.9
| HCB | 62.0 | 30.7 | 7.3
| JPT | 53.1 | 41.6 | 5.3
| YRI | 39.5 | 50.3 | 10.2
| ASW | 56.1 | 35.1 | 8.8
| CHB | 62.0 | 30.7 | 7.3
| CHD | 63.3 | 31.2 | 5.5
| GIH | 70.3 | 27.7 | 2.0
| LWK | 31.8 | 53.6 | 14.5
| MEX | 53.6 | 42.9 | 3.6
| MKK | 18.7 | 47.7 | 33.5
| TSI | 69.6 | 28.4 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21630024
|Title=Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}